These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21709737)

  • 1. ACT HEALTHY: A Combined Cognitive-Behavioral Depression and Medication Adherence Treatment for HIV-Infected Substance Users.
    Daughters SB; Magidson JF; Schuster RM; Safren SA
    Cogn Behav Pract; 2010 Aug; 17(3):309-321. PubMed ID: 21709737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the effect of the Life Enhancement Treatment for Substance Use (LETS ACT) on residential substance abuse treatment retention.
    Magidson JF; Gorka SM; MacPherson L; Hopko DR; Blanco C; Lejuez CW; Daughters SB
    Addict Behav; 2011 Jun; 36(6):615-623. PubMed ID: 21310539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: the life enhancement treatment for substance use (LETS Act!).
    Daughters SB; Braun AR; Sargeant MN; Reynolds EK; Hopko DR; Blanco C; Lejuez CW
    J Clin Psychiatry; 2008 Jan; 69(1):122-9. PubMed ID: 18312046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial.
    Safren SA; O'Cleirigh CM; Bullis JR; Otto MW; Stein MD; Pollack MH
    J Consult Clin Psychol; 2012 Jun; 80(3):404-15. PubMed ID: 22545737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Description and Demonstration of Cognitive Behavioral Therapy to Enhance Antiretroviral Therapy Adherence and Treat Depression in HIV-Infected Adults.
    Newcomb ME; Bedoya CA; Blashill AJ; Lerner JA; O'Cleirigh C; Pinkston MM; Safren SA
    Cogn Behav Pract; 2015 Nov; 22(4):430-438. PubMed ID: 26688659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing Behavioral Activation and Life-Steps for Depression and HIV Medication Adherence in a Community Health Center.
    Magidson JF; Seitz-Brown CJ; Safren SA; Daughters SB
    Cogn Behav Pract; 2014 Nov; 21(4):386-403. PubMed ID: 25419102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of motivational interviewing and cognitive behavioral therapy to improve HIV medication adherence and reduce substance use among HIV-positive men and women: results of a pilot project.
    Parsons JT; Rosof E; Punzalan JC; Di Maria L
    AIDS Patient Care STDS; 2005 Jan; 19(1):31-9. PubMed ID: 15665633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication Adherence in HIV-Positive African Americans: The Roles of Age, Health Beliefs, and Sensation Seeking.
    Sayegh P; Thaler NS; Arentoft A; Kuhn TP; Schonfeld D; Castellon SA; Durvasula RS; Myers HF; Hinkin CH
    Cogent Psychol; 2016; 3(1):. PubMed ID: 29104879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence intervention for HIV-infected persons who use drugs: adaptation, open trial, and pilot randomized hybrid type 1 trial protocol.
    Claborn K; Becker S; Operario D; Safren S; Rich JD; Ramsey S
    Addict Sci Clin Pract; 2018 Apr; 13(1):12. PubMed ID: 29606129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can behavioral theory inform the understanding of depression and medication nonadherence among HIV-positive substance users?
    Magidson JF; Listhaus A; Seitz-Brown CJ; Safren SA; Lejuez CW; Daughters SB
    J Behav Med; 2015 Apr; 38(2):337-47. PubMed ID: 25381605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An effectiveness trial of group cognitive behavioral therapy for patients with persistent depressive symptoms in substance abuse treatment.
    Watkins KE; Hunter SB; Hepner KA; Paddock SM; de la Cruz E; Zhou AJ; Gilmore J
    Arch Gen Psychiatry; 2011 Jun; 68(6):577-84. PubMed ID: 21646576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Initial Open Trial of a Brief Behavioral Activation Treatment for Depression and Medication Adherence in HIV-Infected Patients.
    Tull MT; Berghoff CR; Bardeen JR; Schoenleber M; Konkle-Parker DJ
    Behav Modif; 2018 Mar; 42(2):196-209. PubMed ID: 28799413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving treatment adherence in drug abusers who are HIV-positive.
    Malone SB; Osborne JJ
    Lippincotts Case Manag; 2000; 5(6):236-45; quiz 245-7. PubMed ID: 16398004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial.
    Safren SA; Bedoya CA; O'Cleirigh C; Biello KB; Pinkston MM; Stein MD; Traeger L; Kojic E; Robbins GK; Lerner JA; Herman DS; Mimiaga MJ; Mayer KH
    Lancet HIV; 2016 Nov; 3(11):e529-e538. PubMed ID: 27658881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood trauma and METH abuse among men who have sex with men: Implications for intervention.
    Lopez-Patton M; Kumar M; Jones D; Fonseca M; Kumar AM; Nemeroff CB
    J Psychiatr Res; 2016 Jan; 72():1-5. PubMed ID: 26519763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a behavioral activation treatment for substance use on post-treatment abstinence: a randomized controlled trial.
    Daughters SB; Magidson JF; Anand D; Seitz-Brown CJ; Chen Y; Baker S
    Addiction; 2018 Mar; 113(3):535-544. PubMed ID: 28963853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cognitive Behavioral Therapy-Based Text Messaging Intervention Versus Medical Management for HIV-Infected Substance Users: Study Protocol for a Pilot Randomized Trial.
    Glasner-Edwards S; Patrick K; Ybarra ML; Reback CJ; Rawson RA; Chokron Garneau H; Chavez K; Venegas A
    JMIR Res Protoc; 2016 Jun; 5(2):e131. PubMed ID: 27341852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV/AIDS.
    Ezeabogu I; Copenhaver MM; Potrepka J
    AIDS Care; 2012; 24(3):386-93. PubMed ID: 22250847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.
    Palepu A; Horton NJ; Tibbetts N; Meli S; Samet JH
    Addiction; 2004 Mar; 99(3):361-8. PubMed ID: 14982549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease.
    Thaler NS; Sayegh P; Kim MS; Castellon SA; Hinkin CH
    Arch Clin Neuropsychol; 2015 Mar; 30(2):114-21. PubMed ID: 25589442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.